Subscribe to watch video of Is Black-Only Good Science?

A recent decision by the Federal Drug Administration to approve a prescription drug for self-identified Blacks has been met with mixed reviews.  While some established medical organizations approve of the drug’s use, the implications of practicing medicine based on patients' racial identities is being questioned by other doctors.  Dr. Gregg Bloche, a law professor at Georgetown University and a medical doctor, tells Tony Brown why he feels that the decision to target Black people (at a cost of $400 for a month's supply) might have been predicated on business rather than any reliable science.   (2820)